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An observational study of innate 
immune responses in patients 
with acute appendicitis
toon peeters1,2,3,7, Sandrina Martens1,2,9, Valentino D’Onofrio1,2,3,7, Mark H. T. Stappers3,8, 
Jeroen C. H. van der Hilst1,2, Bert Houben4, Ruth Achten5, Leo A. B. Joosten3,6,7 & 
Inge C. Gyssens 1,2,3,7*
Acute appendicitis is a common surgical emergency worldwide. Exaggerated immune responses 
could be associated with appendicitis. This study aimed at characterizing immune responses towards 
a large variety of gut commensals and pathogens, and pattern recognition receptor (PRR) ligands, 
and investigating the course of systemic inflammation in a prospective cohort of acute appendicitis 
patients. PBMC responses of 23 patients of the cohort and 23 healthy controls were characterized 
more than 8 months post-surgery. Serum cytokine levels were measured in 23 patients at the time of 
appendicitis and after one month. CRP, WBC and percentage of neutrophils were analyzed in the total 
cohort of 325 patients. No differences in PBMC responses were found between patients and controls. 
Stronger IL-10 responses were found following complicated appendicitis. A trend towards lower IL-8 
responses was shown following gangrenous appendicitis. Serum IL-10 and IL-6 were significantly 
elevated at presentation, and IL-6, IL-8 and TNF-α levels were higher in complicated appendicitis. 
Routine biomarkers could predict severity of appendicitis with high specificities, but low sensitivities. 
Cytokine responses in patients following acute appendicitis did not differ from healthy controls. 
Higher serum cytokine levels were found in acute complicated and gangrenous cases. Further research 
into discriminative biomarkers is warranted.
Acute appendicitis is one of the most common surgical emergencies  worldwide1, with a lifetime risk estimated 
between 6 and 17%2, 3. The disease involves inflammation of the appendix, which can be divided into different 
types or stages. It is mostly classified as uncomplicated versus complicated appendicitis. Complicated appendi-
citis is defined by the presence of peritonitis, abscesses and/or perforation. Histologically, a distinction can be 
made between gangrenous appendicitis, which is associated with severe transmural inflammation and areas of 
 necrosis4, and non-gangrenous appendicitis.
The appendix is associated with a mass of lymphatic tissue, indicating a possible role for the appendix in 
immune function. The enteric immune system supports biofilm formation, and compared to other regions in 
the gastrointestinal tract, biofilms are most prominent in the appendix. Considering these observations, and 
the properties and location of the appendix, the theory was introduced that the appendix functions as a safe 
house for commensal bacteria, protecting them from the fecal stream and allowing them to repopulate the gut 
after  trauma5.
Little is understood about the etiology of acute appendicitis. Microbiological causes and infection are often 
 suggested6. There is large variability in micro-organisms detected in the appendix, indicating that a single organ-
ism is unlikely the sole cause of  appendicitis7. The focus of studies into microbial causes of appendicitis has 
open
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therefore shifted towards the microbiome as a whole. The composition of microbiota in the appendix differs 
from other regions in the gastrointestinal  tract8, and there is large variation between individuals. Differences in 
the composition of the fecal microbiome have furthermore been associated with  appendicitis9.
Exaggerated immune responses to commensal bacteria have been associated with auto-immune  diseases10, 
and an overly active immune system has also been associated with appendicitis. After stimulation of peripheral 
blood mononuclear cells (PBMC) with tetanus toxoid, an increase of secretion of interferon gamma (IFN-γ) 
in patients with gangrenous appendicitis compared to negative appendectomy controls has been observed, and 
interleukin (IL)-10 secretion after stimulation is increased in gangrenous compared to phlegmonous appendicitis 
 patients11.
During acute appendicitis, high IL-8 levels can be observed in the appendix, the peritoneal fluid, and accord-
ing to some studies in the serum of  patients12. In contrast to healthy appendices, inflamed appendices also dem-
onstrate an intense cellular tumor necrosis factor (TNF)-α mRNA expression in germinal centers and moderate 
levels of expression throughout the mucosa, while IL-2 mRNA is strongly expressed in the lamina propria and 
moderately in germinal  centers13. Gangrenous appendicitis is associated with inflammatory markers in serum, 
consistent with a Th17  response14.
C-reactive protein (CRP) is a routine inflammatory biomarker which has also been used in the development 
of clinical scoring systems for diagnosing appendicitis, along with white blood cell count (WBC) and percent-
age of  neutrophils15, 16. IL-6 can be considered as a biomarker for appendicitis as well, since high serum levels 
can often be associated with the  condition17. A recent study showed a specific metabolomic and inflammatory 
mediator profile in pediatric acute appendicitis, where IL-6 and CRP were found among the most distinctive 
inflammatory  markers18.
High grade inflammation and tissue damage appear to be a mechanism in the development of appendicitis, 
possibly caused by deviant immune responses. Therefore, we hypothesized that the risk of appendicitis and 
the severity of inflammation are dependent on the individual’s innate immune responses towards components 
of the gut microbiota. The main aim of this study was to characterize potential deviant immune responses to 
stimulation by a large panel of gut bacteria, other commensals and relevant corresponding Pattern Recognition 
Receptor (PRR) ligands.
A second aim was to study the course of systemic inflammation in patients by comparing cytokine levels 
at presentation and one month after surgery, and to identify discriminative biomarkers for clinical severity by 
comparing serum cytokine levels at time of presentation between complicated and uncomplicated appendicitis 
patients.
Methods
Study population and design. Figure 1 depicts the study design. Patients were prospectively recruited in 
the Hasselt Appendicitis Immunology and Environmental Study (HAPPIEST) cohort between June 2012 and 
October 2016. Acute appendicitis was diagnosed at the emergency department of Jessa Hospital, Hasselt, Bel-
gium based on medical history, clinical examination, laboratory results and ultrasound and/or CT scan. Medical 
history, clinical data and laboratory results were recorded. At each time point, study participants filled out ques-
tionnaires. Questionnaires covered demographic data such as age, gender, dietary habits, lifestyle characteristics 
and environmental factors. Following removal, the appendix was sectioned by the surgeon in the operating 
room. A 1 cm section of the tip, the middle and the base were sent to the pathology department to confirm the 
diagnosis and assign histological severity (gangrenous vs non gangrenous), based on the classification by Carr, 
 20004. Severity classification by the surgeon was based on the International Classification of Diseases (ICD)-
9. Appendicitis with generalized peritonitis (540.0) or peritoneal abscess (540.1) was considered complicated, 
appendicitis with no mention of peritonitis or abscess (540.9) was considered uncomplicated. Analyses on sever-
ity were performed based on the pathologist’s and the surgeon’s classification, respectively.
Sampling. Immediately before induction of anesthesia for appendectomy, 2 × 5  ml serum samples were 
taken (Time point 1). Four to six weeks after surgery, patients returning for a control visit donated 2 × 5 ml serum 
(Time point 2). Samples were aliquoted and frozen at − 80 °C.
Patients between the ages of 18 and 50 were invited to return to the hospital after more than 8 months after 
surgery, to guarantee full recovery, and to bring an unrelated age-matched healthy volunteer as paired control. 
Patients and controls were not matched for gender. A total of 23 patients (out of 158 contacted) and 23 controls 
were recruited in pairs. Three 10 ml EDTA blood tubes were collected from patients and controls (Time point 3). 
Samples were immediately transported to the laboratory for peripheral blood mononuclear cell (PBMC) isolation.
2.3 PBMC isolation and stimulation. PBMC isolation was performed on EDTA blood samples collected at Time 
point 3, using Ficoll density centrifugation as described  previously19. PBMCs (0.5*106) were transferred to a 96 
well round bottom plates and stimulated with heat-killed commensal micro-organisms and pathogens, as well 
as pattern recognition receptor (PRR) agonists (Invivogen, San Diego, USA) (Supplementary Table S1) in a final 
volume of 200 µl. After 24 h incubation at 37 °C 5% CO2 supernatants were collected and stored at − 20 °C until 
further analysis.
Cytokine and chemokine levels. Serum cytokine and chemokine levels were determined by enzyme-
linked immunosorbent assays (ELISA), according to manufacturer’s instructions: IL-1β, IL-6, IL-10 and TNF-α 
(Ella, Proteinsimple, California, USA); Alpha-1 antitrypsin (HycultBiotech, Uden, The Netherlands); IL-1RA, 
MIP-1α (Quantikine, R&D systems, Minneapolis, USA); MCP-1 (Duoset ELISA, R&D systems). In supernatant, 
IL-1β, IL-6, IL-8, IL-10, MIP-1α and MCP-1 levels were measured (DuoSet ELISA). A number of supernatant 
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samples were lost during analyses due to technical error or insufficient material. Supplementary Table S2 shows 
the number of participants per measured cytokine/chemokine and stimulus.
Data analysis. Cytokine responses in PBMC were compared between patients and controls using Mann–
Whitney U tests. Serum cytokine levels were compared between Time point 1 and 2 using Wilcoxon signed rank 
tests. Serum cytokine levels at the time of appendicitis were compared between uncomplicated and complicated 
appendicitis, and non-gangrenous and gangrenous appendicitis, using Mann–Whitney U tests. CRP, WBC and 
percentage of neutrophils were compared between uncomplicated and complicated, as well as non-gangrenous 
and gangrenous appendicitis in the total cohort matched for age and gender, using two-tailed T-tests. In order to 
test the diagnostic value of WBC, percentage of neutrophils and CRP as potential biomarkers for disease severity, 
Receiver Operating Characteristics (ROC) curves were made.  Chi2 tests were used to compare uncomplicated 
and complicated, and non-gangrenous and gangrenous appendicitis for elevated clinical laboratory values. Cor-
relations between serum cytokines levels and CRP and WBC at the time of appendicitis, as well as correlation 
between differences in cytokine levels between Time point 1 and 2, were analyzed using Pearson correlation. A 
p < 0.05 was considered statistically significant. All statistical analyses were performed using IBM SPSS statistics 
25.
Ethical statement. The study protocol was approved by the Medical Ethics Committees of Jessa Hospital 
and Hasselt University, Hasselt, Belgium. All experiments were performed in accordance with regulations of 
these institutions. The University Biobank Limburg (UBiLim) meets all national and international standards 
and regulations.
All patients and controls or their parents or guardians included in this study gave written informed consent 
before participation.
The study was registered at Clinicaltrials.gov, under identifier NCT02391675.
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Results
Study population. Patient and control characteristics are listed in Table 1. To ensure that there was no 
selection of patients based on demographics, environment or lifestyle, characteristics were compared between 
the patient population at Time point 3 and the entire HAPPIEST population. To ensure that potential differences 
in immune factors between patients and controls were not a consequence of differences in demographics, envi-
ronment or lifestyle, comparisons on these factors were made between both populations. There were no signifi-
cant differences between patients and controls, or between the patient sample and the entire cohort, regarding 
demographics and exposures. Considering the potential impact of both age and gender on immune function, a 
comparison was made between the mean age of males and females. No significant difference was found (mean 
age respectively 31.50 and 33.45 years; p = 0.308). In the patient sample, there was an equal number of patients 
with complicated appendicitis according to ICD-9 and gangrenous appendicitis (n = 7), yet only three cases were 
classified as both complicated and gangrenous. In the total cohort, 96/325 (30%) of patients were classified as 
complicated according to ICD-9, and 103/325 (32%) were classified as gangrenous. Only 51, however, were clas-
sified as both complicated and gangrenous.
PBMC cytokine responses. Trends could be observed towards higher IL-6 and IL-8 responses in patients 
(n = 23) compared to controls (n = 23) (Fig. 2a, b). No significant differences between patients and controls were 
found in IL1β, IL-6, IL-8, IL-10, MIP-1α or MCP-1 responses towards commensal gut bacteria, pathogens or 
PRR agonists (Fig. 2a, b, Supplementary Fig. S1).
When comparing complicated and uncomplicated appendicitis patients classified according to ICD-9, IL-10 
responses towards S. pyogenes, C. albicans, LPS and Pam3Cys were significantly higher in complicated appendi-
citis patients (Fig. 2c). Other cytokine responses did not significantly differ between uncomplicated and compli-
cated appendicitis patients (Supplementary Fig. S2). Significantly higher IL-6 responses towards FSL-1 (p = 0.026) 
and lower responses towards S. dysgalactiae (p = 0.026) were shown in patients with a history of gangrenous 
appendicitis (Supplementary Fig. S3). A clear trend towards lower IL-8 responses was shown in patients with a 
history of gangrenous appendicitis (Fig. 2d).
Serum cytokine levels and other inflammatory markers. From the sample of 23 patients, five had 
not presented for the control visit (Time point 2). One patient was suffering from sinusitis and was removed 
from this analysis. Serum IL-6 and IL-10 were significantly elevated during acute appendicitis, whereas IL-8 was 
significantly lower during appendicitis (Fig. 3). The decrease in IL-10 at the control visit was correlated with the 
decrease in IL-6 (p < 0.001), IL-1Ra (p = 0.026) and MCP-1 (p = 0.019). The decrease in IL-6 was also correlated 
with a decrease in IL-1Ra (p = 0.023) and MCP-1 (p = 0.020). There was also a correlation in the decrease in 
MCP-1 and IL-1Ra (p = 0.028).
At presentation, serum IL-6, IL-8 and TNF-α levels were significantly higher in complicated versus uncompli-
cated appendicitis patients (Fig. 4). Patients with gangrenous appendicitis had significantly higher serum IL-10 
levels (p = 0.018). CRP at presentation was correlated with IL-1RA (p = 0.003), IL-8 (p = 0.042), IL-10 (p = 0.033), 
TNF-α (p = 0.001) and AAT (p = 0.003). No correlations with WBC could be observed. MIP-1α levels were below 
the detection limit.
In the analysis of the total cohort matched for age and gender, CRP, WBC and percentage of neutrophils were 
significantly higher in complicated appendicitis and in gangrenous appendicitis (p < 0.001, Fig. 5). Supplemen-
tary Tables S3 and S4 show the number of patients with normal and elevated routine biomarkers at presentation 
according to severity, as well as the positive and negative predictive values, and Area Under Curve (AUC) derived 
from ROC curves. The threshold of 10*109 WBC/L could predict uncomplicated appendicitis with specificity of 
0.884 (sensitivity 0.242), and the threshold of 70% neutrophils could predict uncomplicated appendicitis with 
specificity of 0.937 (sensitivity 0.236). The upper normal limit of CRP at 0.5 mg/dl, set in accordance with hospital 
laboratory standards, could predict uncomplicated appendicitis with a specificity of 0.853 (sensitivity 0.326). 
WBC, percentage of neutrophils and CRP could predict non-gangrenous appendicitis with specificity of 0.866 
(sensitivity 0.268), 0.941 (sensitivity 0.237) and 0.897 (sensitivity 0.340), respectively. Patients with a history of 
symptoms for more than 24 h before presenting at the hospital, more frequently had elevated CRP (p = 0.001) 
and WBC (p = 0.010). Combining these biomarkers and delay offered only minimal improvement in predicting 
the severity of appendicitis (data not shown).
Discussion
This study illustrates involvement of the innate immune system in acute appendicitis, and its severity. There was 
a clear trend towards higher IL-10 responses in PBMCs from patients with a history of complicated compared 
to uncomplicated appendicitis, and responses towards a number of specific stimuli were significantly elevated. 
This is in line with increased IL-10 after stimulation of PBMCs in gangrenous appendicitis in earlier  research11. 
IL-6 polymorphisms have previously been associated with severity of  appendicitis20, stronger IL-6 responses in 
patients with a history of gangrenous appendicitis could provide a functional explanation. Remarkably, trends 
towards lower IL-8 responses in patients with a history of gangrenous appendicitis were observed. The poten-
tial differences according to severity of the disease, however, do not necessarily indicate a causal relationship. 
Although time point 3 was specifically selected to provide enough time for potential effects of appendicitis or 
surgery to disappear, disease outcome may still have long term effects on immune function, lasting longer than 
the 8 month period between acute appendicitis and experiments in this study.
No significant differences in PBMC responses were observed between patients and controls. However, since 
trends were observed towards higher IL-6 and especially IL-8 responses in patients, the possibility of a role for 
these two cytokines cannot completely be eliminated. Large variation in immune responses in patients and 
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sample (n = 23)
Healthy Controls 
(n = 23)
p-value1 p-value2n (%) n (%) n (%)
Demographics
 Gender
0.767 0.546  Female 153 (47.1) 11 (47.8) 10 (43.5)
  Male 172 (52.9) 12 (52.2) 13 (56.5)
 Age, mean ± SD (Range) 32.5 ± 18.1 (5–81) 32.2 ± 6.2 (20–41) 32.6 ± 6.4 (18–43) 0.814 0.411
 Marital state
1.000 0.909
  Single 26 (8.4) 2 (9.1) 2 (9.1)
  Living with partner, family or in community 284 (91.6) 20 (90.9) 20 (90.9)
  Missing 15 1 1
 Living area
0.531 0.373
  Rural 129 (41.5) 7 (31.8) 9 (40.9)
  Urban 182 (58.5) 15 (68.2) 13 (59.1)
  Missing 14 2 2
Acute appendicitis, IBD
 Family history of acute appendicitis
0.082 0.521
  Yes 168 (57.3) 10 (50.0) 5 (23.8)
  No 125 (42.7) 10 (50.0) 16 (76.2)
  Missing 32 3 2
 Family history of Inflammatory Bowel Disease
0.859 0.472
  Yes 11 (4,4) 1 (9.1) 1 (7.1)
  No 237 (95,6) 10 (90.9) 13 (92.9)
  Don’t know 44 0 0
  Missing 33 12 9
 Complicated (ICD-9)
0.910  Yes 96 (29.5) 7 (30.4) n.a.
  No 229 (70.5) 16 (69.6) n.a.
 Gangrenous (pathology)
  Yes 103 (31.7) 7 (30.4) n.a.
0.845
  No 222 (68.3) 16 (69.6) n.a.
 Time between first symptoms and presentation (hours)
  Complicated (ICD-9)
0.091
   Less than 24 11 (12.0) 0 (0.0) n.a.
   24–48 29 (31.5) 5 (71.4) n.a.




   Less than 24 61 (27.5) 5 (31.3) n.a.
   24–48 85 (38.3) 7 (43.8) n.a.




   Less than 24 20 (20.0) 1 (14.3) n.a.
   24–48 37 (37.0) 6 (85.7) n.a.




   Less than 24 52 (24.3) 4 (25.0) n.a.
   24–48 77 (36.0) 6 (37.5) n.a.
   More than 48 85 (39.7) 6 (37.5) n.a.
   Missing 8 0
Exposures
 Living area in youth
0.894 0.470
  Rural 159 (51.3) 10 (43.5) 10 (45.5)
  Urban 151 (48.7) 13 (56.5) 12 (54.5)









sample (n = 23)
Healthy Controls 
(n = 23)
p-value1 p-value2n (%) n (%) n (%)
 Contact with farm animals during youth
0.286 0.340
  Seldom or never 181 (58.0) 11 (47.8) 14 (63.6)
  Daily to monthly 131 (42.0) 12 (52.2) 8 (36.4)
  Missing 13 0 1
 Living with pets
0.746 0.883
  Yes 178 (56.7) 11 (55.0) 11 (50.0)
  No 136 (43.3) 9 (45.0) 11 (50.0)
  Missing 11 3 1
 Breastfeeding
0.102 0.537
  No 87 (33.2) 5 (26.3) 9 (52.9)
  Yes 175 (66.8) 14 (73.7) 8 (47.1)
  Don’t know 45 4 5
  Missing 18 0 1
  Duration
0.368 0.212
   Less than 3 months 47 (39.8) 2 (25.0) 0 (0.0)
   3–6 months 38 (32.2) 5 (62.5) 4 (100.0)
   More than 6 months 33 (28.0) 1 (12.5) 0 (0.0)
   Don’t know 57 6 4
   Missing 0 0 0
 Vegan/vegetarian
1.000 0.495
  Yes 7 (2.2) 1 (4.5) 1 (4.5)
  No 305 (97.8) 21 (95.5) 21 (95.5)
  Missing 13 1 1
 Meat consumption
0.379 0.567
  Daily 235 (79.1) 15 (75.0) 18 (90.0)
  Weekly 57 (19.2) 4 (20.0) 2 (10.0)
  Monthly 5 (1.7) 1 (5.0) 0 (0.0)
  Missing 21 1 1
 Fruit consumption
0.269 0.987
  Daily 130 (41.8) 9 (40.9) 13 (61.9)
  Weekly 132 (42.4) 10 (45.5) 8 (38.1)
  Monthly 30 (9.6) 2 (9.1) 0 (0.0)
  Never 19 (6.1) 1 (4.5) 0 (0.0)
  Don’t know 1 0 1
  Missing 13 1 1
 Vegetable consumption
0.550 0.771
  Daily 259 (82.7) 20 (90.9) 21 (95.5)
  Weekly 48 (15.3) 2 (9.1) 1 (4.5)
  Monthly 1 (0.3) 0 (0.0) 0 (0.0)
  Never 5 (1.6) 0 (0.0) 0 (0.0)
  Missing 12 1 1
 Fiber-rich vegetable consumption
0.167 0.283
  Daily 34 (11.2) 2 (9.1) 2 (9.1)
  Weekly 207 (68.1) 13 (59.1) 18 (81.8)
  Monthly 51 (16.8) 7 (31.8) 2 (9.1)
  Never 12 (3.9) 0 (0.0) 0 (0.0)
  Don’t know 7 0 0
  Missing 14 1 1
 Sugar containing drink consumption
0.190
  Daily – 12 (57.1) 15 (68.2)
  Weekly – 4 (19.0) 5 (22.7)
  Monthly – 4 (19.0) 0 (0.0)
  Never – 1 (4.8) 2 (9.1)
  Don’t know – 1 0
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controls may have influenced all analyses. Further research in a larger sample is therefore warranted. Another 
explanation for these findings could be that deviant immune responses associated with acute appendicitis are 
confined to the appendix itself or the enteric immune  system21.
A strength of this study is the selection of control individuals for the stimulation experiments from the envi-
ronment of patients in order to eliminate potential environmental influences; in addition, the time point of the 
stimulation experiments was late enough to guarantee full recovery and avoid effects of trained immunity in the 
majority of patients. These effects are pronounced after 3 months, but wane after 6 months to 1 year22. There was 
no selection for the stimulation experiments other than the fact that active and healthy former patients were 
willing to return to the hospital with a non-related healthy age-matched individual as paired control. An addi-
tional strength is the use of classification both by the surgeon and the pathologist. As seen in the results in this 
study, there was no large overlap between patients with complicated appendicitis and gangrenous appendicitis. 
Using both classification systems allowed for easier comparison with the  literature11, 14 and provided a broader 
image of different pathological processes in acute appendicitis. Using a large variety of relevant stimuli and 
measuring multiple cytokine and chemokine concentrations also contributed to a higher level of certainty that 
innate immune responses in patients with a history of appendicitis were not significantly different from healthy 
control individuals in this population.
Elevated IL-6 and IL-10 levels in serum of acute appendicitis patients are in line with previous  findings23, 
although the decrease in serum levels of these markers one month following appendicitis has, to our knowledge, 
not been documented. Since no other serum markers assessed in this study were significantly elevated, these 
cytokines are likely the most important as drivers of acute appendicitis.
There was no correlation of IL-6 levels with CRP or WBC measurement at presentation, IL-10 was correlated 
with CRP. A possible explanation can be a difference in the kinetics of these biomarkers during the inflammatory 
process. Correlations between IL-10, IL-6, IL-1Ra and MCP-1 indicate that a combination of these factors could 
be of importance in appendicitis.
High serum levels of IL-8 in patients compared to healthy controls were not found in this study. However, 
all inflammatory cytokines examined in this study tended to be higher in complicated versus uncomplicated 
appendicitis. Serum IL-10 was significantly higher in gangrenous appendicitis. Differences in results between 
these classification systems possibly indicate the different systemic consequences of pathologic processes in the 
appendix versus peritonitis and periappendicular abscesses. AAT and MCP-1 showed no discriminative power 
as biomarkers for severity, which to our knowledge has not been described in the literature.
Analyses on the entire cohort showed the ability to predict uncomplicated and non-gangrenous appendicitis 
using CRP, WBC or percentage of neutrophils with high specificity, indicating that low values could be of use 
as markers for less severe appendicitis. Apart from their role in scores for the diagnosis of acute appendicitis, 
their possible use in predicting disease severity has been the focus of other studies as  well24–26. The possibility to 
differentiate between uncomplicated and complicated, non-gangrenous and gangrenous appendicitis at presenta-




sample (n = 23)
Healthy Controls 
(n = 23)
p-value1 p-value2n (%) n (%) n (%)
 Antibiotic use
0.101 0.281
  More than once per month 1 (0.3) 0 (0.0) 0 (0.0)
  Monthly 15 (4.8) 0 (0.0) 0 (0.0)
  Seldom 250 (80.4) 15 (71.4) 20 (90.9)
  Never 45 (14.5) 6 (28.6) 2 (9.1)
  Missing 14 2 1
 Probiotic use
0.239 0.649
  Daily 63 (20.2) 6 (28.6) 5 (22.7)
  Weekly 64 (20.5) 4 (19.0) 8 (36.4)
  Monthly 26 (8.3) 2 (9.5) 5 (22.7)
  Seldom 88 (28.2) 7 (33.3) 8 (36.4)
  Never 71 (22.8) 2 (9.5) 0 (0.0)
  Missing 13 2 1
 Smoke status
0.282 0.217
  Current smoker 56 (22.0) 2 (9.1) 6 (27.3)
  Past smoker 61 (23.9) 9 (40.9) 8 (36.4)
  Non-smoker 132 (51.8) 11 (50.0) 8 (36.4)
  Passive 6 (2.4) 0 (0.0) 0 (0.0)
  Missing 70 1 1
Table 1.  Characteristics of patients with a history of appendicitis and controls. 1 Patient sample versus 
controls. 2 HAPPIEST cohort versus patient sample.
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Figure 2.  Cytokine responses towards commensal gut bacteria, pathogens and PRR agonists. (a, b) IL-6 
and IL-8 responses in patients (n = 23) and controls (n = 23). (c) IL-10 responses in patients with a history of 
complicated (n = 16) and uncomplicated (n = 7) appendicitis. (d) IL-8 responses in patients with a history of 
non-gangrenous (n = 16) and gangrenous (n = 7) appendicitis. Whiskers indicate 10–90 percentile.
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Figure 2.  (continued)
surgery in cases of uncomplicated  appendicitis27, 28. High WBC, CRP and percentage neutrophils could indicate 
a higher possibility of severe appendicitis. However, low values did not rule this out, and basing a decision for 
surgery on these biomarkers is not without risk. Furthermore, CRP levels and WBC were associated with delay, 
which is known to be the main risk factor of more severe  appendicitis29. As there are correlations between bio-
markers and delay, combining these factors did not improve prediction of severity.
In conclusion, ex-vivo experiments of PBMC stimulation showed little to no evidence of innate immune 
dysfunction as an inherent characteristic of patients with a history of acute appendicitis, although differences in 
responses between patients with a history of complicated and uncomplicated appendicitis do show a possible link. 
Systemic inflammation and correlations between serum levels of cytokines warrant further research into the pos-
sibility of combining markers that can be valuable in the determining the severity of appendicitis at presentation.
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Figure 3.  Serum cytokine concentrations in patients at the time of appendicitis and after one month of 
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Figure 4.  Serum cytokine levels in patients with uncomplicated (n = 16) and complicated (n = 7) appendicitis.
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Figure 5.  Routine biomarkers according to severity in the total cohort matched for age and gender. (a) 
Uncomplicated (n = 95) versus Complicated (n = 95) according to ICD-9. (b) Non-Gangrenous (n = 97) versus 
Gangrenous (n = 97) according to pathology. Bars indicate mean with SEM.
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Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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